EU aims to create ‘single market for medicines’ with overhaul of pharma rules

EU aims to create ‘single market for medicines’ with overhaul of pharma rules

April 26, 2023, Financial Times

Peter Bogaert's commentary appeared in a Financial Times article about the European Commission's proposal to revise the European Union's pharmaceutical legislation--the first overhaul of pharmaceutical legislation in 20 years.  As part of the legislation, the European Commission is advancing a plan to cut the number of years of market exclusivity — the period before a drugmaker faces competition from generic manufacturers — from 10 to eight years

According to Peter, the exclusivity reforms were unlikely to increase innovation. “The incentive value of the exclusivities mainly matters at the time when a company decides what clinical development programmes to invest in,” he said.

Click here to read the full article.